ESALY - Eisai Co Ltd (ESALF) Management on Q1 2021 Results - Earnings Call Transcript
Eisai Co Ltd (ESALF)
Q1 2021 Earnings Conference Call
August 03, 2020 03:00 AM ET
Company Participants
Ryohei Yanagi - Chief Financial Officer
Ivan Cheung - Senior VP & President of Neurology Business Group
Terushige Iike - Senior VP & President of Oncology Business Group
Takashi Owa - VP and Chief Medicine Creation
Yasushi Okada - Representative Corporate Officer and COO
Teiji Kimura - Chief Discovery Officer
Haruo Naito - CEO Representative Corporate Officer and Director
Conference Call Participants
Hidemaru Yamaguchi - Citigroup
Seiji Wakao - Mitsibishi UFJ Morgan Stanley
Motoya Kohtani - Nomura Securities